1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Thromboembolic Events: new trials by email Literature Review of Thromboembolic Events trials Research Report on Thromboembolic Events
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) Enoxaparin Sodium Injection 30 mg BID, Enoxaparin Sodium Injection 40 mg QD - Trauma, Surgery | Phase 4 | Unknown | Oregon Health and Science University | 606 | 2014-02-01 | 2024-04-03 |
Thromboembolism (1) · Venous Thrombosis (1) · Wounds and Injuries (1)
Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Thrombosis (1) · Vascular Diseases (1)
BID protein, human (1) · Enoxaparin (1) · enoxaparin sodium (1)
Oregon Health and Science University (1)
United States (1)